Appears On
Episode Appearances
Pharmaceutical Executive · May 13, 2026
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
“Argues that pharmaceutical expertise requires intellectual honesty and recognizing knowledge limits”
PROTAC Technology and Protein DegradationCancer Therapy InnovationGLP-1 Receptor Agonist Therapies
View Analysis